We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.39B
AUM Growth
+$344M
Cap. Flow
+$229M
Cap. Flow %
16.52%
Top 10 Hldgs %
16.24%
Holding
318
New
46
Increased
121
Reduced
103
Closed
19

Sector Composition

Rank Sector Weight
1 Industrials 19.51%
2 Technology 15.09%
3 Consumer Discretionary 11.18%
4 Healthcare 10.43%
5 Consumer Staples 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HURN icon
176
Huron Consulting
HURN
$2.44B
$2.09M 0.15%
33,399
+27,593
+475% +$1.61M
SSYS icon
177
Stratasys
SSYS
$773M
$1.99M 0.14%
14,745
+9,342
+173% +$1.08M
MED icon
178
Medifast
MED
$143M
$1.98M 0.14%
75,897
+47,731
+169% +$1.22M
DGII icon
179
Digi International
DGII
$3.07B
$1.98M 0.14%
163,527
-7,750
-5% -$83.3K
POOL icon
180
Pool Corp
POOL
$7.54B
$1.97M 0.14%
33,940
+21,487
+173% +$1.19M
LFCR icon
181
Lifecore Biomedical
LFCR
$186M
$1.97M 0.14%
162,205
+17,630
+12% +$211K
BRK.B icon
182
Berkshire Hathaway Class B
BRK.B
$1.12T
$1.94M 0.14%
16,350
LHX icon
183
L3Harris
LHX
$53.5B
$1.92M 0.14%
27,526
-2,000
-7% -$127K
TFM
184
DELISTED
THE FRESH MARKET, INC COM STK
TFM
$1.92M 0.14%
+47,388
New +$2.2M
NVDQ
185
DELISTED
Novadaq Technologies Inc.
NVDQ
$1.91M 0.14%
115,639
-5,450
-5% -$90.3K
OMCL icon
186
Omnicell
OMCL
$1.71B
$1.88M 0.14%
73,695
-3,500
-5% -$83.6K
HAIN icon
187
Hain Celestial
HAIN
$56.8M
$1.88M 0.14%
41,384
+26,202
+173% +$1.08M
AX icon
188
Axos Financial
AX
$5.71B
$1.86M 0.13%
94,788
+56,736
+149% +$1.02M
CMPR icon
189
Cimpress
CMPR
$2.32B
$1.86M 0.13%
32,681
+20,714
+173% +$1.15M
ABCO
190
DELISTED
Advisory Board Co
ABCO
$1.85M 0.13%
29,070
+18,427
+173% +$1.17M
PIKE
191
DELISTED
PIKE CORPORATION COM STK (NC)
PIKE
$1.82M 0.13%
171,821
-8,450
-5% -$88.1K
CEVA icon
192
CEVA Inc
CEVA
$1.07B
$1.8M 0.13%
118,206
+80,737
+215% +$1.22M
SFLY
193
DELISTED
Shutterfly, Inc.
SFLY
$1.79M 0.13%
+35,226
New +$1.78M
ACNT icon
194
Ascent Industries
ACNT
$142M
$1.78M 0.13%
115,684
+12,853
+12% +$206K
LQDT icon
195
Liquidity Services
LQDT
$1.29B
$1.78M 0.13%
78,360
+52,612
+204% +$1.32M
DIS icon
196
Walt Disney
DIS
$181B
$1.71M 0.12%
22,369
-1,568
-7% -$109K
QCOR
197
DELISTED
QUESTCOR PHARMA INC
QCOR
$1.67M 0.12%
30,623
+19,386
+173% +$1.15M
TIP icon
198
iShares TIPS Bond ETF
TIP
$14.5B
$1.52M 0.11%
13,856
+690
+5% +$77K
PCOM
199
DELISTED
Points.com Inc. Common Shares
PCOM
$1.51M 0.11%
59,617
+37,158
+165% +$876K
ATTU
200
DELISTED
Attunity Ltd
ATTU
$1.51M 0.11%
+146,007
New +$1.32M

Similar funds

Rice Hall James & Associates's Q4 2013 Portfolio in Review

As of Q4 2013, Rice Hall James & Associates held 318 positions worth $1.39B, up 33% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Rice Hall James & Associates deployed $229M of net new capital in Q4 2013, opening 46 new positions and adding to 121 existing holdings. Its largest new stake was Albany International: 427,571 shares worth $15.4M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Encompass Health, an estimated $3.94M trimmed.

  • Rice Hall James & Associates's largest Q4 2013 buy was Albany International: 427,571 shares worth $15.4M.
  • Rice Hall James & Associates added most to Integrated Device Technology I in Q4 2013, an estimated $10M increase.
  • Rice Hall James & Associates's biggest Q4 2013 reduction was Encompass Health, cutting an estimated $3.94M.
  • Rice Hall James & Associates fully exited Wendy's in Q4 2013, selling an estimated $12.3M.
  • Rice Hall James & Associates's ten largest holdings make up 16% of its $1.39B portfolio in Q4 2013.
  • Rice Hall James & Associates opened 46 new positions and closed 19 in Q4 2013.
  • Rice Hall James & Associates's portfolio value rose 33% quarter-over-quarter to $1.39B.

Based on Rice Hall James & Associates's 13F filing for Q4 2013, filed 11 Feb 2014.